People
Cellbox Solutions announces the expansion of its Board of Directors and the appointment of a new CEO - Wolfgang Kintzel will start as Chief Executive Officer effective March 1, 2020.
Mallinckrodt Files Chapter 11 for its Generics Business as it Reaches $1.6 Billion Opioid Settlement
In addition to the settlement and bankruptcy, Mallinckrodt entered into a debt refinancing agreement, including an $800 million loan that will be used to repay some outstanding debt and acquire some outstanding stocks.
Corteva, Inc. announced that Nayaki Nayyar has been elected to Corteva’s Board of Directors, effective February 21, 2020.
Pawel Rosikiewicz - co-founder of “SwissAI Machine Learning Meetups” and of the SwissAI foundation - joins GenomSys in the role of Scientific Communications Expert.
Katherine High, the longtime head of research and development at Spark Therapeutics, is stepping down from the company as it prepares to be absorbed by Swiss pharma giant Roche.
Biopharma and life sciences companies strengthen their leadership teams and board with this week’s Movers & Shakers.
Kazia Therapeutics is company focused on developing anti-cancer drugs.
A group of unions and consumer organizations have banded together in opposition to the $63 billion merger citing concerns that it will create a monopoly and harm competition.
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
Virginia, which is part of the BioSpace Hotbed region known as BioCapital, is home to an $8 billion biopharma market that employs more than 26,545 people.
PRESS RELEASES